Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia: A Randomized, Double-blind, Controlled Study
The DOI matches its Crossref record, with a small difference in title or year; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Treatment strategies against acute neuroleptic-induced akathisia (NIA) include anticholinergic (antimuscarinic) agents, dopamine agonists, GABAergic agents, beta-blockers, benzodiazepines, and serotonin antagonists. However, many patients who have acute akathisia fail to respond. In previous studies, mianserin and vitamin B6 were found to be effective in the treatment of acute akathisia. The purpose of this study was to compare the efficacy of B(6), mianserin and placebo in the treatment of acute NIA. Sixty schizophrenia and schizoaffective inpatients who have NIA were randomly divided to receive vitamin B(6) 1,200 mg/d, mianserin 15 mg/d, or placebo for 5 days, in a double-blind design. The Barnes Akathisia Rating Scale, Brief Psychiatric Rating Scale, and Clinical Global Impression were used to assess the severity of NIA and psychotic symptoms. The assessment was made at baseline and daily for the duration of the study. Compared with the placebo group, the vitamin B(6)-treated and mianserin-treated patients showed a significant improvement in the subjective (P < 0.0001), subjective distress (P < 0.0001), and global (P < 0.0001) subscales. The objective subscale did not show significant positive results (P = 0.056), but there was a trend toward symptom amelioration in both groups. A reduction of at least 2 points on the Barnes Akathisia Rating Scale global subscale was noted in the vitamin B(6) group (13/23, 56%) as well as in the mianserin groups (13/20, 65%), and in only one patient in the placebo group (1/17, 6%; P < 0.0005). Our results indicate that high doses of B(6) and a low dose of mianserin may be a useful addition to current treatments of NIA. The efficacy of vitamin B(6) and mianserin suggests that the pathophysiology of acute NIA is heterogeneous with the various subtypes of acute NIA responding differently to the various pharmacological approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, 10% to 20% of patients do not respond to mirtazapine and mianserin, which suggests that other mechanisms, apart from serotonin blockade, may be involved in AIA.31”
From Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-Analysis (2024) · cites this paper as [31]
In the citing paper
“Vitamin B6 may play a role, notably as a corrector of dopamine imbalance and a free radical scavenger.30,31”
From Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-Analysis (2024) · cites this paper as [31]
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
Serotonin-dopamine interaction and its relevance to schizophrenia
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.466 · Cited by 823
Akathisia Variants and Tardive Dyskinesia
Barnes, T. R. E. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790320042006 · Cited by 255
Neuroleptic-induced akathisia: a review
Adler, L. A., Angrist, B., Reiter, S. R., & Rotrosen, J. (1989) · Psychopharmacology · doi:10.1007/bf00443404 · Cited by 131
Non-nutritional uses of vitamin B6
Bender, D. A. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599000082 · Cited by 129
The Pharmacologic Treatment of Neuroleptic-Induced Akathisia
FLEISCHHACKER, W. W., ROTH, S. D., & KANE, J. M. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199002000-00003 · Cited by 120
A critical review of akathisia, and its possible association with suicidal behaviour
Hansen, L. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.325 · Cited by 119
Findling, R. L., Maxwell, K., Scotese-Wojtila, L., Huang, J., Yamashita, T. S., & Wiznitzer, M. (1997) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025861522935 · Cited by 113
The Epidemiology of Drug-induced Akathisia: Part I. Acute Akathisia
Sachdev, P. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.3.431 · Cited by 100
Research works printed but not linked: 8
- Poyurovsky, 1998, Isr J Psychiatry Relat Sci, 35, 70
- DeVeaugh-Geiss, 1978, J Clin Psychiatry, 39, 573
- Devaux, 1987, Semin Hop Paris, 63, 1476
- Lerner, 1999, Clin Neuropharmacol, 22, 241
- Holman, 1995, J Aust Coll Nutr Environ Med, 14, 5
- Cabrini, 1998, Biochem Mol Biol Int, 46, 689
- Miller, 1990, Psychopharmacol Bull, 26, 373
- Poyurovsky, 2003, J Clin Psychopharmacol, 23, 305
Cited by
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & WFSBP Task force on Treatment Guidelines for Schizophrenia (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.739708 · Cited by 416
Vitamin B6: A Long Known Compound of Surprising Complexity
Mooney, S., Leuendorf, J.-E., Hendrickson, C., & Hellmann, H. (2009) · Molecules · doi:10.3390/molecules14010329 · Cited by 299
Diet and Psychosis: A Scoping Review
Aucoin, M., LaChance, L., Cooley, K., & Kidd, S. A. (2018) · Neuropsychobiology · doi:10.1159/000493399 · Cited by 139
Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
Salem, H., Nagpal, C., Pigott, T. A., & Teixeira, A. L. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161208153644 · Cited by 117
Japanese Society of Neuropsychopharmacology (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12193 · Cited by 117
Metadata
- Authors
- Miodownik, C., Lerner, V., Statsenko, N., Dwolatzky, T., Nemets, B., Berzak, E., & Bergman, J.
- Affiliations
- Ben-Gurion University of the Negev (IL)
- Corresponding author
- Miodownik, Chanoch
- Lerner, Vladimir
- Statsenko, Nikolay
- Dwolatzky, Tzvi
- Nemets, Boris
- Berzak, Elina
- Venue
- Clinical Neuropharmacology
- Published
- 2006-03
- Volume
- 29
- Issue
- 2
- Pages
- 68-72
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2003451122
- Cited by
- 47
- References
- 32
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 7 · 2017: 2 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 1
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- neuroleptic-induced akathisia, vitamin B6, mianserin, antipsychotic adverse effects, schizophrenia, schizoaffective disorder, serotonin antagonists, placebo comparison
- MeSH terms
- Acute Disease, Adrenergic alpha-Antagonists, Adult, Aged, Bipolar Disorder, Double-Blind Method, Female, Humans, Male, Mianserin, Middle Aged, Psychotic Disorders, Schizophrenia, Antipsychotic Agents, Vitamins, Akathisia, Drug-Induced, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia: A Randomized, Double-blind, Controlled Study. https://app.cochat.ai/papers/10.1097/00002826-200603000-00002
- The paper
- Miodownik, C., Lerner, V., Statsenko, N., Dwolatzky, T., Nemets, B., Berzak, E., & Bergman, J. (2006). Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia: A Randomized, Double-blind, Controlled Study. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-200603000-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.